Scotiabank initiated coverage of Gilead (GILD) with an Outperform rating and $140 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Galapagos price target raised to $32 from $28 at RBC Capital
- Gilead reports ASCENT-07 study misses primary endpoint
- Gilead announces new Livdelzi long-term data
- Gilead Sciences: Balanced Hold Rating Amidst Strong HIV Performance and Modest Diversification Challenges
- GILD, COF, WELL: Top 3 Stocks to Buy Today, Backed by Technical Analysis